Specific immunotherapy for allergic rhinitis in Italy: The doctors' points of view

M. Larosa, G. Ciprandi, C. F. Tesi, G. Cadario, A. Fiocchi, F. Frati, A. Romano

Research output: Contribution to journalArticlepeer-review


Specific immunotherapy (SIT) is the unique causal treatment for allergy, but its prescription is quite restricted. A perspective and cross-sectional survey based on telephone interviews was carried out in Italy to evaluate the profile of doctors prescribing SIT for allergic rhinitis. A total of 540 doctors were interviewed, 200 of whom are GPs, 60 allergists, 60 ENT specialists, 100 familial paediatricians, 60 hospital paediatricians and 60 pulmonologists. Significant differences concern diagnostic and therapeutic management of allergic rhinitis, mainly regarding SIT prescription. The allergist is the most important consultant who prescribes SIT, as opposed to the paediatrician. This study therefore provides the evidence that doctors' behaviour towards SIT depends on the type of graduate studies.

Original languageEnglish
Pages (from-to)251-254
Number of pages4
JournalInternational Journal of Immunopathology and Pharmacology
Issue number1
Publication statusPublished - Jan 2009


  • Allergic rhinitis
  • Doctors
  • Educational level
  • Perscription
  • Specific immunotherapy

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'Specific immunotherapy for allergic rhinitis in Italy: The doctors' points of view'. Together they form a unique fingerprint.

Cite this